Literature DB >> 21493530

Successful treatment of equine sarcoids by topical aciclovir application.

S Stadler1, C Kainzbauer, R Haralambus, W Brehm, E Hainisch, S Brandt.   

Abstract

Based on the anecdotally reported eradication of a sarcoid using aciclovir cream, the curative potential of this ointment was investigated in 22 sarcoid-affected horses referred to the Equine Clinic Tillysburg, Austria, between 2006 and 2009. Sarcoid disease was diagnosed by clinical examination and bovine papillomavirus types 1 and 2 from intact skin and tumour tissue. As nine horses had more than one lesion, a total of 47 sarcoids were treated by daily topical application of aciclovir 5 per cent cream for a period of two to six months; in four horses, surgical tumour ablation was performed before treatment. Disease parameters, including the tumour type, number, location and size, were recorded before and after aciclovir therapy. All 47 (100 per cent) of the sarcoids responded to treatment, with complete tumour regression observed for 32 (68 per cent) lesions and no recurrences reported thus far. Incomplete resolution was observed for 15 (32 per cent) lesions, probably due to their thickness. Aciclovir is proposed to be routinely used for the treatment of mild-type sarcoids and as an adjuvant therapeutic agent in combination with surgery.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21493530     DOI: 10.1136/vr.c5430

Source DB:  PubMed          Journal:  Vet Rec        ISSN: 0042-4900            Impact factor:   2.695


  4 in total

1.  Owners' perception of the efficacy of Newmarket bloodroot ointment in treating equine sarcoids.

Authors:  Sophie Wilford; Ella Woodward; Bettina Dunkel
Journal:  Can Vet J       Date:  2014-07       Impact factor: 1.008

2.  Autologous vaccination for the treatment of equine sarcoids: 18 cases (2009-2014).

Authors:  Caitlin C Rothacker; Ashley G Boyle; David G Levine
Journal:  Can Vet J       Date:  2015-07       Impact factor: 1.008

3.  Equine sarcoids: Bovine Papillomavirus type 1 transformed fibroblasts are sensitive to cisplatin and UVB induced apoptosis and show aberrant expression of p53.

Authors:  Margaret Finlay; Zhengqiang Yuan; Iain M Morgan; M Saveria Campo; Lubna Nasir
Journal:  Vet Res       Date:  2012-12-04       Impact factor: 3.683

4.  In vitro assessment of triterpenoids NVX-207 and betulinyl-bis-sulfamate as a topical treatment for equine skin cancer.

Authors:  Lisa Annabel Weber; Anne Funtan; Reinhard Paschke; Julien Delarocque; Jutta Kalbitz; Jessica Meißner; Karsten Feige; Manfred Kietzmann; Jessika-Maximiliane V Cavalleri
Journal:  PLoS One       Date:  2020-11-05       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.